SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(del Favero J)
 

Sökning: WFRF:(del Favero J) > Prevention of chemo...

  • Roila, F.Medical Oncology Division, Silvestrini Hospital, 06156S Andrea delle Fratte, Perugia, Italy (författare)

Prevention of chemotherapy- and radiotherapy-induced emesis : Results of the 2004 Perugia International Antiemetic Consensus Conference

  • Artikel/kapitelEngelska2006

Förlag, utgivningsår, omfång ...

  • Elsevier BV,2006
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-50326
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-50326URI
  • https://doi.org/10.1093/annonc/mdj078DOI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:for swepub-publicationtype

Anmärkningar

  • Background: In the late 1990s, several professional organizations convened antiemetic guideline groups and published the findings of these expert panels. Each of these documents was based on analyses of the available published trials and provided nearly similar recommendations. Nonetheless, small differences in emetic risk categories and treatment recommendations led to confusion in antiemetics selection. With the emergence of new findings and agents since the guidelines were initially published, many of the oncology professional societies have updated the antiemetic guidelines. Materials and methods: A literature review up to March 2004 was carried out using MEDLINE with evaluation of the evidence by an expert panel composed of 23 oncology professionals in clinical medicine, medical oncology, radiation oncology, oncology nursing, statistics, pharmacy, medical policy and decision making, and pharmacology. The experts represented nine oncology professional societies and came from 11 different countries on four continents. Results: Recommendations on antiemetic regimens to prevent emesis induced by high, moderate, low and minimal risk chemotherapy were suggested as well as management of anticipatory emesis. Furthermore, recommendations for refractory emesis, emesis induced by high-dose chemotherapy and radiotherapy and for antiemetics in children receiving chemotherapy were elaborated. Conclusions: Recommendations about antiemetic prophylaxis in patients receiving treatment with chemo- and radiotherapy have been updated by representatives of nine oncological organizations. © 2005 European Society for Medical Oncology.

Ämnesord och genrebeteckningar

  • 5-HT3-receptor antagonists
  • Acute emesis
  • Aprepitant
  • Delayed emesis
  • Dexamethasone
  • Metoclopramide
  • NATURAL SCIENCES
  • NATURVETENSKAP

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Aapro, M.Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland (författare)
  • Ballatori, E.Statistics Unit, L'Aquila, Italy (författare)
  • Borjeson, S.Division of Nursing Science, Linkoping University, Linkoping, Sweden (författare)
  • Clark-Snow, R.A.University of Kansas Cancer Center, Kansas City, KS, United States (författare)
  • Del, Favero A.Del Favero, A., Department of Internal Medicine and Oncological Sciences, Perugia, Italy (författare)
  • Einhorn, L.H.Walther Cancer Institute, Indianapolis, IN, United States (författare)
  • Feyer, P.Viventes Clinics Berlin-Neukölln, Berlin, Germany (författare)
  • Gralla, R.J.New York Lung Cancer Alliance, New York, NY, United States (författare)
  • Grunberg, S.M.University of Vermont, Burlington, VT, United States (författare)
  • Herrstedt, J.Copenhagen University Hospital, Copenhagen, Denmark (författare)
  • Hesketh, P.J.Caritas St. Elizabeth's Medical Center, Boston, MA, United States (författare)
  • Kaiser, R.University Clinic, Goettingen, Germany (författare)
  • Koeller, J.University of Texas Health Science Center, San Antonio, TX, United States (författare)
  • Kris, M.G.Memorial Sloan-Kettering Cancer Center, New York, NY, United States (författare)
  • Maranzano, E.Radiation Oncology Center, 'S.S. Maria' Hospital, Terni, Italy (författare)
  • Molassiotis, A.School of Nursing, University of Manchester, Manchester, United Kingdom (författare)
  • Olver, I.Royal Adelaide Hospital Cancer Center, Adelaide, SA, Australia (författare)
  • Osoba, D.QOL Consulting, West Vancouver, BC, Canada (författare)
  • Rapoport, B.L.The Medical Oncology Centre of Rosebank, Johannesburg, South Africa (författare)
  • Rittenberg, C.Rittenberg Oncology Consulting, Metaire, LA, United States (författare)
  • Tonato, M.Perugia Regional Cancer Center, Perugia, Italy (författare)
  • Warr, D.Princess Margaret Hospital, University of Toronto, Toronto, Ont., Canada (författare)
  • Medical Oncology Division, Silvestrini Hospital, 06156S Andrea delle Fratte, Perugia, ItalyInstitut Multidisciplinaire d'Oncologie, Genolier, Switzerland (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Annals of Oncology: Elsevier BV17:1, s. 20-280923-75341569-8041

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy